Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Tramadol
evidence profile

Centrally acting opioid analgesic / monoamine reuptake inhibitor. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Tramadol: conceptual scientific illustration for Sexual Medicine Pharmacology
VISUAL GUIDE · Tramadol

Sexual Medicine Pharmacology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

A controlled opioid analgesic authorised for bounded pain contexts, not premature ejaculation; EAU positions off-label PE use cautiously as third-line because long-term safety and addiction potential remain concerns.

01

ENTITY FACTS

What should readers identify first?

MOLECULETramadol
PHARMACOLOGYCentrally acting opioid analgesic / monoamine reuptake inhibitor
PRIMECORE CLASSA
EVIDENCE GRADEA
RESEARCH TOPICSexual Medicine Pharmacology
LAST REVIEWED2026-08-29

What remains unknown?

English translation is not yet verified for 3 excerpt(s). This is a language gap, not an absence of risks or uncertainty.

Read original excerpts (Thai / mixed language)
  • หลักฐาน PE ไม่เปลี่ยน tramadol ให้เป็นยาที่อนุมัติสำหรับ PE และไม่ลดระดับความเสี่ยงของ opioid
  • คำว่า third-line ไม่ใช่คำแนะนำให้ทดลองใช้เอง แต่เป็นตำแหน่งในแนวทางที่ต้องอาศัยการประเมินและความระมัดระวัง
  • ผลต่อการหลั่งไม่ใช่หลักฐานเพิ่มความต้องการ รักษาภาวะหย่อนสมรรถภาพทางเพศ หรือให้ประโยชน์ทางเพศโดยรวม

What limits these conclusions?

Insufficient data in the current dataset

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. DailyMed — current tramadol hydrochloride tablets label
  2. Thai FDA — NYTRADOL registration
  3. EAU — Disorders of ejaculation
  4. EAU — Sexual and Reproductive Health methodology
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Tramadol?

Tramadol is described pharmacologically as Centrally acting opioid analgesic / monoamine reuptake inhibitor. A controlled opioid analgesic authorised for bounded pain contexts, not premature ejaculation; EAU positions off-label PE use cautiously as third-line because long-term safety and addiction potential remain concerns.

Does Tramadol have strong evidence?

PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Tramadol approved everywhere?

No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice